Opthea to Present at J.P. Morgan Healthcare Conference
Ticker: OPTEY · Form: 6-K · Filed: Dec 19, 2024 · CIK: 1815620
Sentiment: neutral
Topics: conference-presentation, healthcare
TL;DR
Opthea presenting at JPM Healthcare Conference in Jan '25 - expect updates.
AI Summary
Opthea Limited announced on December 19, 2024, that it will present at the 43rd Annual J.P. Morgan Healthcare Conference. The conference is scheduled to take place in January 2025 in San Francisco, California. This presentation will provide an update on the company's progress and strategic outlook.
Why It Matters
Opthea's participation in a major healthcare conference signals its intent to engage with investors and industry peers, potentially influencing its stock valuation and future partnerships.
Risk Assessment
Risk Level: low — This filing is a routine announcement of participation in a conference and does not contain new financial or operational information that would significantly alter risk.
Key Players & Entities
- Opthea Limited (company) — Registrant
- J.P. Morgan Healthcare Conference (company) — Event
- 43rd Annual J.P. Morgan Healthcare Conference (company) — Event
FAQ
When and where will Opthea Limited present?
Opthea Limited will present at the 43rd Annual J.P. Morgan Healthcare Conference in January 2025 in San Francisco, California.
What is the purpose of this filing?
This is a Form 6-K report of foreign issuer, announcing Opthea's participation in the J.P. Morgan Healthcare Conference.
What type of company is Opthea Limited?
Opthea Limited is a company in the Biological Products sector, specifically not including diagnostic substances.
What is the filing date and period of report?
The filing date is December 19, 2024, and the conformed period of report is also December 19, 2024.
Does Opthea file annual reports under Form 20-F or 40-F?
Opthea Limited files annual reports under Form 20-F.
Filing Stats: 152 words · 1 min read · ~1 pages · Grade level 11.4 · Accepted 2024-12-19 06:02:45
Filing Documents
- opt_-_opthea_43rd_j.p.mo.htm (6-K) — 24KB
- opt-ex99_1.htm (EX-99.1) — 19KB
- img260626642_0.jpg (GRAPHIC) — 61KB
- img260626642_1.jpg (GRAPHIC) — 61KB
- 0000950170-24-138204.txt ( ) — 212KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereto duly authorized. OPTHEA LIMITED (Registrant) By: /s/ Frederic Guerard Name: Frederic Guerard Title: Chief Executive Officer Date: 12/19/2024